Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen R Laird

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 4, 2011
Non-oxime pyrazole based inhibitors of B-Raf kinaseBradley J Newhouse, Joshua D Hansen, Jonas Grina, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2014
Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-Raf(V600E) kinaseSteve Wenglowsky, Li Ren, Jonas Grina, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2011
Non-oxime inhibitors of B-Raf(V600E) kinaseLi Ren, Steve Wenglowsky, Greg Miknis, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2009
Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitorsMakoto Shiozaki, Hiroto Imai, Katsuya Maeda, et al.
Journal of Medicinal Chemistry|July 30, 2024
Identification of the Clinical Candidate <b>PF-07284890</b> (<b>ARRY-461</b>), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of CancerLi Ren, David Moreno, Brian R Baer, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2012
The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinaseLi Ren, Kateri A Ahrendt, Jonas Grina, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationshipsSteve Wenglowsky, Kateri A Ahrendt, Alex J Buckmelter, et al.
Journal of Medicinal Chemistry|February 26, 2009
Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead explorationRalph P Robinson, Leonard Buckbinder, Amber I Haugeto, et al.
Journal of Medicinal Chemistry|March 23, 2011
Discovery of (1S,2R,3R)-2,3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: novel and highly selective aggrecanase inhibitorsMakoto Shiozaki, Katsuya Maeda, Tomoya Miura, et al.
Journal of Medicinal Chemistry|May 31, 2024
Discovery of Potent and Selective Covalent Inhibitors of HER2<sup>WT</sup> and HER2<sup>YVMA</sup>Erik J Hicken, Karin Brown, Natalie C Dwulet, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|May 4, 2011
Non-oxime pyrazole based inhibitors of B-Raf kinaseBradley J Newhouse, Joshua D Hansen, Jonas Grina, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2014
Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-Raf(V600E) kinaseSteve Wenglowsky, Li Ren, Jonas Grina, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2011
Non-oxime inhibitors of B-Raf(V600E) kinaseLi Ren, Steve Wenglowsky, Greg Miknis, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2009
Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitorsMakoto Shiozaki, Hiroto Imai, Katsuya Maeda, et al.
Journal of Medicinal Chemistry|July 30, 2024
Identification of the Clinical Candidate <b>PF-07284890</b> (<b>ARRY-461</b>), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of CancerLi Ren, David Moreno, Brian R Baer, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2012
The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinaseLi Ren, Kateri A Ahrendt, Jonas Grina, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationshipsSteve Wenglowsky, Kateri A Ahrendt, Alex J Buckmelter, et al.
Journal of Medicinal Chemistry|February 26, 2009
Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead explorationRalph P Robinson, Leonard Buckbinder, Amber I Haugeto, et al.
Journal of Medicinal Chemistry|March 23, 2011
Discovery of (1S,2R,3R)-2,3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: novel and highly selective aggrecanase inhibitorsMakoto Shiozaki, Katsuya Maeda, Tomoya Miura, et al.
Journal of Medicinal Chemistry|May 31, 2024
Discovery of Potent and Selective Covalent Inhibitors of HER2<sup>WT</sup> and HER2<sup>YVMA</sup>Erik J Hicken, Karin Brown, Natalie C Dwulet, et al.
Pageof 4